RNA modulates physiological and neuropathological protein phase transitions

Area of Science:

• Neurobiology
• Molecular Biology
• Biochemistry

Background:

• RNA-binding proteins (RBPs) aggregate in neurodegenerative diseases like ALS and FTD.
• These proteins mislocalize from the nucleus to cytoplasmic inclusions.
• Liquid-liquid phase separation (LLPS) is implicated in the formation of these pathological aggregates.

Purpose of the Study:

• To review the mechanisms of RNA-mediated phase transitions of RBPs.
• To examine how RNA properties influence RBP LLPS.
• To understand the dual role of RNA in physiological and pathological RBP aggregation.

Main Methods:

• Literature review of studies on RBP aggregation and LLPS.
• Analysis of molecular properties of RNA-RBP interactions.
• Examination of RNA's role in membraneless organelle (MLO) formation and function.

Main Results:

• RNA is a key component and modulator of RBP-containing MLOs.
• RNA can both promote and inhibit RBP phase separation.
• RNA length, sequence, and structure critically influence RBP LLPS.

Conclusions:

• RNA plays a complex role in regulating RBP phase behavior.
• Understanding RNA-RBP interactions is crucial for neurodegenerative disease research.
• Modulating these interactions may offer therapeutic strategies for ALS and FTD.